{"transactions":[{"id":707443,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:32:38.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084438","document":"tm2620629-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084438/tm2620629-5_4seq1.xml","form_type":"4"}},{"id":748748,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:04:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":48407,"source":{"system":"sec-edgar","filing":"0001193125-26-260250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260250/ownership.xml","form_type":"4"}},{"id":928259,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T01:05:03.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001193125-26-029895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029895/ownership.xml","form_type":"4"}},{"id":928258,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:05:03.000Z","date":"2026-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":6780,"price":21.23,"value":143939.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not wittheld by the Issuer."}],"balance_after":31532,"source":{"system":"sec-edgar","filing":"0001193125-26-029895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029895/ownership.xml","form_type":"4"}},{"id":928257,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:05:03.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":13.71,"value":143955.0,"ownership":{"direct":true},"balance_after":38312,"source":{"system":"sec-edgar","filing":"0001193125-26-029895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029895/ownership.xml","form_type":"4"}},{"id":1101988,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:22.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016535/ownership.xml","form_type":"4"}},{"id":1133956,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-27T20:19:35.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":26500,"derivative":{"exercise_price":2.11,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001437749-25-018497","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925018497/rdgdoc.xml","form_type":"4"}},{"id":1208484,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-14T00:00:04.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":false,"shares":9746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.18,"exercise_date":"2016-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":9746},"source":{"system":"sec-edgar","filing":"0000950170-25-039037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025039037/ownership.xml","form_type":"4"}},{"id":1208483,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T00:00:04.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":2491,"price":99.64,"value":248203.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover the exercise price relating to the exercise of stock options to purchase shares, which are scheduled to expire in 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.64 and $99.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":27812,"source":{"system":"sec-edgar","filing":"0000950170-25-039037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025039037/ownership.xml","form_type":"4"}},{"id":1208482,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T00:00:04.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":true,"shares":9746,"price":25.18,"value":245404.28,"ownership":{"direct":true},"balance_after":30303,"source":{"system":"sec-edgar","filing":"0000950170-25-039037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025039037/ownership.xml","form_type":"4"}},{"id":1213589,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:05.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20557,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037522/ownership.xml","form_type":"4"}},{"id":1213588,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:05.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":20557,"source":{"system":"sec-edgar","filing":"0000950170-25-037522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037522/ownership.xml","form_type":"4"}},{"id":1469117,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:08.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025336","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025336/ownership.xml","form_type":"4"}},{"id":1519523,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:05:03.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month."}],"balance_after":10000,"derivative":{"exercise_price":21.11,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-016227","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924016227/rdgdoc.xml","form_type":"4"}},{"id":1599796,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:42.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3679,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3679},"source":{"system":"sec-edgar","filing":"0000950170-24-026617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026617/ownership.xml","form_type":"4"}},{"id":1599795,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T01:00:42.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":1846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025."}],"balance_after":18174,"source":{"system":"sec-edgar","filing":"0000950170-24-026617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026617/ownership.xml","form_type":"4"}},{"id":1718228,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T22:06:37.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":20000,"derivative":{"exercise_price":21.71,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-034025","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923034025/rdgdoc.xml","form_type":"4"}},{"id":1844589,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:37:33.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039720/doc4.xml","form_type":"4"}},{"id":1939982,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:36:58.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-23-001113","document":"zk2329429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001113/zk2329429.xml","form_type":"4"}},{"id":1939981,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:36:58.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-23-001113","document":"zk2329429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001113/zk2329429.xml","form_type":"4"}},{"id":1939980,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:36:58.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":6857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted as per the annual grant of options to directors. These options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6857,"derivative":{"exercise_price":1.62,"expiration_date":"2033-03-21","underlying":"American Depositary Shares","underlying_shares":6857},"source":{"system":"sec-edgar","filing":"0001178913-23-001113","document":"zk2329429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001113/zk2329429.xml","form_type":"4"}},{"id":1964287,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:00:43.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3257,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001209191-23-017405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017405/doc4.xml","form_type":"4"}},{"id":1964286,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:00:43.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":1523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024."}],"balance_after":16328,"source":{"system":"sec-edgar","filing":"0001209191-23-017405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017405/doc4.xml","form_type":"4"}},{"id":2152991,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:08:24.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051007/doc4.xml","form_type":"4"}},{"id":2341224,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-09T21:07:13.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-001024","document":"zk2227456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001024/zk2227456.xml","form_type":"4"}},{"id":2341223,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-09T21:07:13.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in their entirety on March 16, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-001024","document":"zk2227456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001024/zk2227456.xml","form_type":"4"}},{"id":2345785,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-09T01:07:12.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":5077,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5077,"derivative":{"exercise_price":80.42,"exercise_date":"2023-03-07","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":5077},"source":{"system":"sec-edgar","filing":"0001209191-22-017353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017353/doc4.xml","form_type":"4"}},{"id":2345784,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T01:07:12.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":2953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023."}],"balance_after":14805,"source":{"system":"sec-edgar","filing":"0001209191-22-017353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017353/doc4.xml","form_type":"4"}},{"id":2742786,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2021-04-21T21:16:03.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001104659-21-053235","document":"tm2113689-5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000110465921053235/tm2113689-5_4.xml","form_type":"4"}},{"id":2807361,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-06T01:04:44.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":5518,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5518,"derivative":{"exercise_price":87.11,"exercise_date":"2022-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":5518},"source":{"system":"sec-edgar","filing":"0001209191-21-018419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018419/doc4.xml","form_type":"4"}},{"id":2807360,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-06T01:04:44.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":2726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022."}],"balance_after":11852,"source":{"system":"sec-edgar","filing":"0001209191-21-018419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018419/doc4.xml","form_type":"4"}},{"id":3242235,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:05:49.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":3685,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3685,"derivative":{"exercise_price":114.47,"exercise_date":"2021-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":3685},"source":{"system":"sec-edgar","filing":"0001209191-20-014235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014235/doc4.xml","form_type":"4"}},{"id":3242234,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-29T01:05:49.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."}],"balance_after":9126,"source":{"system":"sec-edgar","filing":"0001209191-20-014235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014235/doc4.xml","form_type":"4"}},{"id":3620933,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-03-05T01:05:06.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":3213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":3213,"derivative":{"exercise_price":145.48,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":3213},"source":{"system":"sec-edgar","filing":"0001209191-19-016034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016034/doc4.xml","form_type":"4"}},{"id":3620932,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T01:05:06.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":7051,"source":{"system":"sec-edgar","filing":"0001209191-19-016034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016034/doc4.xml","form_type":"4"}},{"id":4009166,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-03-07T23:05:37.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":4820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":4820,"derivative":{"exercise_price":71.45,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":4820},"source":{"system":"sec-edgar","filing":"0001209191-18-017793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017793/doc4.xml","form_type":"4"}},{"id":4009165,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-07T23:05:37.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":3418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock award represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":5418,"source":{"system":"sec-edgar","filing":"0001209191-18-017793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017793/doc4.xml","form_type":"4"}},{"id":4387337,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-15T01:46:20.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of Sarepta's 2017 Annual Meeting of Stockholders."}],"balance_after":12350,"derivative":{"exercise_price":32.63,"expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0001209191-17-020686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117020686/doc4.xml","form_type":"4"}},{"id":4387336,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-15T01:46:20.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of Sarepta's 2017 Annual Meeting of Stockholders."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-17-020686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117020686/doc4.xml","form_type":"4"}}]}